Clinical Trial Update: Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a four-drug regimen (romidepsin, gemcitabine, dexamethasone, cisplatin) in peripheral T-cell lymphoma and diffuse large B-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Gemcitabine (Gemcitabine)
• Romidepsin (Istodax) (romidepsin)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Peripheral T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma | Phase 1 | Status: COMPLETED